Keyword: Jean-Luc Herbeaux
News
28.02.2022
-
Hovione has appointed Jean-Luc Herbeaux as Hovione’s Chief Executive Officer (CEO), effective April 1, 2022. He will succeed Guy Villax, who has been the company’s CEO...
Markets & Companies
16.10.2020
-
So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...
News
04.05.2020
-
Jean-Luc Herbeaux has been appointed as Chief Operating Officer (COO) of Hovione, effective May 1, 2020.
News
20.08.2015
- German specialty chemicals group Evonik has opened its first applied technology laboratory for medical devices. Located in Shanghai, China, the facility will support medical device...
Strategy & Management
01.10.2014
- 1. What roles do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in the drug discovery/development value chain today, and how will their...
News
22.08.2011
- Evonik has appointed Dr. Hans-Josef Ritzert as its regional president of greater China, effective Sept. 1. Ritzert currently heads the company's Exclusive Synthesis & Pharma Amino...
